Effect of vitamin d injection supplements on foot ulcer status  in type II diabetic

Not Applicable

• Conditions: Diabetic foot ulcer.; Diabetic ulcer; E10, E11,

• Registration Number: IRCT2015041321740N1
• Lead Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusion criterion: patients with diabetic foot ulcers; Exclusion criteria: pregnancy; presence of associated autoimmune disease; use of anti convulsants (which alter the metabolism of vitamin D); concomitant osteomyelitis; low blood pressure; use of antibiotic in recently month; skin tumors on venous ulcers and/or lymphedema; ulcers in legs of other cause than venous insufficiency; patients with renal insufficiency; paresthesias of lower limbs and the need for surgical debridement.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Foot ulcers scale patients. Timepoint: Before and after interventuon. Method of measurement: With Auto cad 2010.

Secondary Outcome Measures

Name	Time	Method
Serum 25(OH)D3. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( ng/dl).;FBS. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mg/dl).;Serum CRP. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mg/l).;Serum WBC. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( micro/l).;Serum ESR. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mm/hr).